MedPath

ONESOURCE SPECIALTY PHARMA LIMITED

🇮🇳India
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

5

FDA:5

Drug Approvals

Acetylcysteine

Approval Date
Sep 12, 2025
FDA

Methohexital Sodium

Approval Date
May 22, 2025
FDA

Thiamine Hydrochloride

Approval Date
Nov 11, 2024
FDA

Carboprost Tromethamine

Approval Date
Aug 1, 2023
FDA

mycophenolate mofetil

Approval Date
Apr 11, 2023
FDA

Clinical Trials

No trials found

News

OneSource Specialty Pharma Partners with Xbrane Biopharma for Commercial Biosimilar Manufacturing

OneSource Specialty Pharma Limited has entered a strategic manufacturing partnership with Sweden-based Xbrane Biopharma AB to support commercial production of biosimilar products targeting EUR 23 billion in annual peak sales.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.